Health-related quality of life of patients receiving extended-release tolterodine for overactive bladder.

@article{Kelleher2002HealthrelatedQO,
  title={Health-related quality of life of patients receiving extended-release tolterodine for overactive bladder.},
  author={Con J. Kelleher and Pat Ray Reese and Andreas M. Pleil and Gary J. Okano},
  journal={The American journal of managed care},
  year={2002},
  volume={8 19 Suppl},
  pages={S608-15}
}
OBJECTIVE To compare the health-related quality of life (HRQoL) of overactive bladder (OAB) patients foilowing treatment with tolterodine extended-release (ER) 4 mg once daily versus placebo. STUDY DESIGN Multinational, placebo-controlled, randomized, double-blind 12-week study. POPULATION Patients with urinary frequency ( > or = 8 micturitions/24 hours over a 7-day period), urge incontinence ( > or = 5 episodes/week), and symptoms of OAB for at least 6 months were eligible for inclusion… CONTINUE READING

From This Paper

Topics from this paper.
24 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

Similar Papers

Loading similar papers…